Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocugen Inc 263 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 USA

P: 484-328-4701

Description:

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 1,147,311
Shares Outstanding, K 199,186
Annual Sales, $ 40 K
Annual Net Income, $ -21,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,760 K
60-Month Beta 4.70
% of Insider Shareholders 3.65%
% of Institutional Shareholders 28.45%
Float, K 191,916
% Float 96.35%

Growth:

1-Year Return 1,802.87%
3-Year Return -80.21%
5-Year Return -94.84%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/09/21
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 61.54%
EPS Growth vs. Prev Year 28.57%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-60 on 09/30/19

OCGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.27%
Return-on-Assets % -59.14%
Profit Margin % -54,550.00
Net Margin % N/A
Debt/Equity 0.01
Price/Sales 29.49
Price/Cash Flow N/A
Price/Book 11.71
Book Value/Share 0.54
Interest Coverage -29.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar